Timothy C. Hancox

1.7k total citations
6 papers, 597 citations indexed

About

Timothy C. Hancox is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Timothy C. Hancox has authored 6 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Timothy C. Hancox's work include Cancer therapeutics and mechanisms (2 papers), Synthesis and biological activity (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Timothy C. Hancox is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Synthesis and biological activity (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Timothy C. Hancox collaborates with scholars based in United Kingdom, New Zealand and United States. Timothy C. Hancox's co-authors include Heather Maecker, Klaus Okkenhaug, Khaled Ali, Dalya R. Soond, Bart Vanhaesebroeck, Ee Lyn Lim, Hicham Bouabe, Roberto Piñeiro, Wayne Pearce and Cheryl L. Scudamore and has published in prestigious journals such as Nature, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Timothy C. Hancox

6 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy C. Hancox United Kingdom 6 239 233 230 153 106 6 597
Thilo J. Heckrodt United States 7 160 0.7× 146 0.6× 335 1.5× 184 1.2× 21 0.2× 13 638
Marie‐Paule Hildebrand France 14 120 0.5× 336 1.4× 43 0.2× 271 1.8× 59 0.6× 17 630
David J. Calderwood United States 9 116 0.5× 180 0.8× 72 0.3× 133 0.9× 52 0.5× 12 381
Anna Lucia Fallacara Italy 17 98 0.4× 299 1.3× 47 0.2× 230 1.5× 87 0.8× 28 603
Chie Oshita Japan 7 217 0.9× 185 0.8× 192 0.8× 48 0.3× 58 0.5× 10 372
Jonathan S. George United States 6 154 0.6× 115 0.5× 77 0.3× 85 0.6× 73 0.7× 7 471
Naoto Ohi Japan 12 169 0.7× 276 1.2× 57 0.2× 86 0.6× 23 0.2× 19 519
Moacyr Oliveira United States 4 237 1.0× 392 1.7× 64 0.3× 40 0.3× 47 0.4× 4 593
Sian Anderson United Kingdom 5 254 1.1× 275 1.2× 32 0.1× 104 0.7× 44 0.4× 7 502
Yibin Zeng United States 15 111 0.5× 208 0.9× 142 0.6× 416 2.7× 42 0.4× 25 768

Countries citing papers authored by Timothy C. Hancox

Since Specialization
Citations

This map shows the geographic impact of Timothy C. Hancox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy C. Hancox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy C. Hancox more than expected).

Fields of papers citing papers by Timothy C. Hancox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy C. Hancox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy C. Hancox. The network helps show where Timothy C. Hancox may publish in the future.

Co-authorship network of co-authors of Timothy C. Hancox

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy C. Hancox. A scholar is included among the top collaborators of Timothy C. Hancox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy C. Hancox. Timothy C. Hancox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Ali, Khaled, Dalya R. Soond, Roberto Piñeiro, et al.. (2014). Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer. Nature. 510(7505). 407–411. 397 indexed citations
2.
Folkes, Adrian, Stewart Baker, Irina Chuckowree, et al.. (2008). The discovery of GDC-0941: A potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer. Cancer Research. 68. 5 indexed citations
3.
Wang, Shouming, Hamish Ryder, Paul Depledge, et al.. (2002). Studies on Quinazolinones as Dual Inhibitors of Pgp and MRP1 in Multidrug Resistance. Bioorganic & Medicinal Chemistry Letters. 12(4). 571–574. 32 indexed citations
4.
Vicker, Nigel, Irina Chuckowree, Adrian Folkes, et al.. (2002). Novel Angular Benzophenazines:  Dual Topoisomerase I and Topoisomerase II Inhibitors as Potential Anticancer Agents. Journal of Medicinal Chemistry. 45(3). 721–739. 116 indexed citations
5.
Baker, Stephen & Timothy C. Hancox. (1999). The synthesis of [2.2.2]bicyclooctane and [3.1.1]bicycloheptane based amino acids as constrained glutamate analogues. Tetrahedron Letters. 40(4). 781–784. 8 indexed citations
6.
Bailey, Patrick D., et al.. (1994). Highly enantioselective synthesis of pipecolic acid derivatives via an asymmetric aza-Diels–Alder reaction. Journal of the Chemical Society Chemical Communications. 2543–2544. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026